Gregory Fanning is a biotech R&D executive and advisor with over 20 years of experience in early-stage research. Currently, Fanning serves as Chief Business Officer at AstriVax and advises multiple organizations, including RNAssist and SCG Cell Therapy. Previously, Fanning held significant roles at Johnson & Johnson, where they led hepatitis research and innovation initiatives in China. Fanning earned a DPhil in Genetics and Immunology from the University of Oxford.
Location
Charre, France
This person is not in the org chart
This person is not in any teams
This person is not in any offices